Related Experiment Videos
Outcome variables in presymptomatic individuals at higher risk of developing Alzheimer disease
S Gauthier1, J Montplaisir, D Petit
1McGill Centre for Studies in Aging, Hôpital Sacré-Coeur de Montréal, Montreal, Canada.
Alzheimer Disease and Associated Disorders
|January 1, 1996
Abstract:
The treatment of individuals at risk of Alzheimer disease is feasible in well-designed, placebo-controlled, double-blind studies. The favored design would be life survival for cognitive impairment, alterations in instrumental ADL, and selected biological variables.